Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis

Neuroepidemiology

Volumn 47, Issue 3-4, 2017, Pages 181-191

  Islam, Md Mohaimenul ^a,b   Iqbal, Usman ^b   Walther, Bruno ^b   Atique, Suleman ^a,b   Dubey, Navneet Kumar ^a   Nguyen, Phung Anh ^a,b   Poly, Tahmina Nasrin ^d   Masud, Jakir Hossain Bhuiyan ^a,b   Li, Yu Chuan ^a,b,c   Shabbir, Syed Abdul ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Benzodiazepines; Dementia; Diabetic; Heterogeneity; Hypertension

Indexed keywords

BENZODIAZEPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; BENZODIAZEPINE DERIVATIVE;

AGED; BODY MASS; COMORBIDITY; DATA EXTRACTION; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; DRUG EXPOSURE; DRUG USE; EUROPE; GEOGRAPHIC DISTRIBUTION; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; NORTH AMERICA; PATIENT IDENTIFICATION; POLYPHARMACY; PRESCRIPTION; PUBLISHING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; FEMALE; MALE; OBSERVATIONAL STUDY;

AGED; BENZODIAZEPINES; DEMENTIA; FEMALE; HUMANS; MALE; OBSERVATIONAL STUDIES AS TOPIC; RISK FACTORS;

EID: 85008343596     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000454881     Document Type: Review

References (50)

1. McCullagh CD, Craig D, McIlroy SP, Passmore AP: Risk factors for dementia. Adv Psychiatr Treat 2001; 7: 24-31.
2. Catindig JA, Venketasubramanian N, Ikram MK, Chen C: Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci 2012; 321: 11-16.
3. World Health Organization: Dementia: A Public Health Priority. Geneva, World Health Organization, 2012.
4. Ferri CP, Prince M, Brayne C, et al: Global prevalence of dementia: a Delphi consensus study. Lancet 2006; 366: 2112-2117.
5. Plassman BL, Langa KM, Fisher GG, et al: Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29: 125-132.
6. Shively S, Scher AI, Perl DP, Diaz-Arrastia R: Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol 2012; 69: 1245-1251.
7. Saczynski JS, Beiser A, Seshadri S, et al: Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 2010; 75: 35-41.
8. Roman GC: Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology 2003; 22: 161-164.
9. Kennelly SP, Lawlor BA, Kenny RA: Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord 2009; 2: 241-260.
10. Linden M, Bär T, Helmchen H: Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16: 461-480.
11. Rickels K: Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction? Psychother Psychosom 2013; 82: 351-352.
12. Stahl SM: Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J Clin Psychiatry 2002; 63: 756-757.
13. Mamdani M, Rapoport M, Shulman KI, et al: Mental health-related drug utilization among older adults: prevalence, trends, and costs. Am J Geriatr Psychiatry 2005; 13: 892-900.
14. Hogan DB, Maxwell CJ, Fung TS, Ebly EM: Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003; 10: 72-77.
15. Liberati A, Altman DG, Tetzlaff J, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151:W65-W94.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
17. Shih HI, Lin CC, Tu YF, et al: An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore) 2015; 94:e809.
18. Imfeld P, Bodmer M, Jick SS, Meier CR: Benzodiazepine use and risk of developing Alzheimer's disease or vascular dementia: a casecontrol analysis. Drug Saf 2015; 38: 909-919.
19. Lagnaoui R, Bégaud B, Moore N, et al: Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol 2002; 55: 314-318.
20. Billioti de Gage S, Moride Y, Ducruet T, et al: Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ 2014; 349: g5205.
21. Wu CS, Wang SC, Chang IS, Lin KM: The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 2009; 17: 614-620.
22. Wu CS, Ting TT, Wang SC, et al: Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry 2011; 19: 151-159.
23. Gray SL, Dublin S, Yu O, et al: Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 2016; 352:i90.
24. Gallacher J, Elwood P, Pickering J, et al: Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health 2012; 66: 869-873.
25. Billioti de Gage S, Bégaud B, Bazin F, et al: Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012; 345:e6231.
26. Shash D, Kurth T, Bertrand M, et al: Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study. Alzheimers Dement 2016; 12: 604-613.
27. Higgins JP, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011.
28. Zhong G, Wang Y, Zhang Y, Zhao Y: Association between benzodiazepine use and dementia: a meta-analysis. PLoS One 2015; 10:e0127836.
29. Lara VP, Caramelli P, Teixeira AL, et al: High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia. Clin Chim Acta 2013; 423: 18-22.
30. Justin BN, Turek M, Hakim AM: Heart disease as a risk factor for dementia. Clin Epidemiol 2013; 5: 135-145.
31. Yamada M, Kasagi F, Sasaki H, et al: Association between dementia and midlife risk factors: the radiation effects research foundation adult health study. J Am Geriatr Soc 2003; 51: 410-414.
32. Posner HB, Tang MX, Luchsinger J, et al: The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58: 1175-1181.
33. Craft S: Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007; 4: 147-152.
34. Johansson L, Guo X, Waern M, et al: Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain 2010; 133(pt 8):2217-2224.
35. Higgins JP, Green S: Cochrane Handbook for Systematic Reviews of Interventions. Wiley Online Library, 2008.
36. Lu L, Fu Dl, Li HQ, et al: Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies. PLoS One 2014; 9:e85781.
37. Corrada MM, Brookmeyer R, Paganini-Hill A, et al: Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol 2010; 67: 114-121.
38. Borenstein AR, Copenhaver CI, Mortimer JA: Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20: 63-72.
39. Ptok U, Papassotiropoulos A, Maier W, Heun R: Advanced parental age: a risk factor for Alzheimer's disease or depression in the elderly? Int Psychogeriatr 2000; 12: 445-451.
40. Luchsinger JA, Patel B, Tang MX, et al: Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007; 64: 392-398.
41. Fitzpatrick AL, Kuller LH, Lopez OL, et al: Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336-342.
42. Peters R, Poulter R, Warner J, et al: Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 2008; 8: 36.
43. Aggarwal NT, Bienias JL, Bennett DA, et al: The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology 2006; 26: 140-146.
44. O'Keefe JH, Bybee KA, Lavie CJ: Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007; 50: 1009-1014.
45. Luchsinger JA, Tang MX, Siddiqui M, et al: Alcohol intake and risk of dementia. J Am Geriatr Soc 2004; 52: 540-546.
46. Xu G, Liu X, Yin Q, et al: Alcohol consumption and transition of mild cognitive impairment to dementia. Psychiatry Clin Neurosci 2009; 63: 43-49.
47. Abbott RD, White LR, Ross GW, et al: Walking and dementia in physically capable elderly men. JAMA 2004; 292: 1447-1453.
48. Mehlig K, Skoog I, Waern M, et al: Physical activity, weight status, diabetes and dementia: a 34-year follow-up of the population study of women in Gothenburg. Neuroepidemiology 2014; 42: 252-259.
49. Almeida OP, Garrido GJ, Lautenschlager NT, et al: Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am J Geriatr Psychiatry 2008; 16: 92-98.
50. Fratiglioni L, Paillard-Borg S, Winblad B: An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004; 3: 343-353.